SEC FIlings Archives - Page 6 of 19

23 Jan

SEC FIlings

General statement of acquisition of beneficial ownership

January 23, 2023
Posted by Ulisses

20 Jan

SEC FIlings

Notice of Effectiveness

January 23, 2023
Posted by Ulisses

20 Jan

SEC FIlings

424B3: Prospectus [Rule 424(b)(3)]

January 22, 2023
Posted by Ulisses

17 Jan

SEC FIlings

424B3: Prospectus [Rule 424(b)(3)]

January 17, 2023
Posted by Ulisses

17 Jan

SEC FIlings

424B3: Prospectus [Rule 424(b)(3)]

January 17, 2023
Posted by Ulisses

17 Jan

SEC FIlings

Securities and Exchange Commission

January 17, 2023
Posted by Ulisses

17 Jan

SEC FIlings

Securities and Exchange Commission

January 17, 2023
Posted by Ulisses

17 Jan

SEC FIlings

Current report

January 17, 2023
Posted by Ulisses

12 Jan

SEC FIlings

General form for registration of securities under the Securities

January 12, 2023
Posted by Ulisses

09 Jan

SEC FIlings

Prospectus [Rule 424(b)(3)]

January 9, 2023
Posted by Ulisses

SEC FIlings

General statement of acquisition of beneficial ownership

Notice of Effectiveness

424B3: Prospectus [Rule 424(b)(3)]

424B3: Prospectus [Rule 424(b)(3)]

424B3: Prospectus [Rule 424(b)(3)]

Securities and Exchange Commission

Securities and Exchange Commission

Current report

General form for registration of securities under the Securities

Prospectus [Rule 424(b)(3)]

test according

Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024

Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales For The Fiscal Year Ended December 31, 2023, Based On Currently Available Information

Scilex Holding Company Announces Filing of a New Drug Submission (NDS) to Health Canada’s Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without

Scilex Holding Company Announces that According to Prescription Data from Symphony Health, ZTlido® is the Most Prescribed Non-Opioid Branded Pain Treatment By Pain Specialists